Johnson & Johnson announces new ICOTYDE data
Johnson & Johnson said it has new ICOTYDE (icotrokinra) data in difficult-to-treat plaque psoriasis with durability through 2 years.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.